9,499 Shares in Medtronic plc (NYSE:MDT) Acquired by Raiffeisen Bank International AG

Raiffeisen Bank International AG bought a new position in shares of Medtronic plc (NYSE:MDT - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 9,499 shares of the medical technology company's stock, valued at approximately $756,000.

Other large investors have also bought and sold shares of the company. Mainstream Capital Management LLC bought a new stake in Medtronic during the 4th quarter worth approximately $26,000. Stephens Consulting LLC grew its stake in shares of Medtronic by 145.7% during the 4th quarter. Stephens Consulting LLC now owns 344 shares of the medical technology company's stock worth $27,000 after acquiring an additional 204 shares in the last quarter. Rakuten Securities Inc. grew its stake in shares of Medtronic by 753.8% during the 4th quarter. Rakuten Securities Inc. now owns 333 shares of the medical technology company's stock worth $27,000 after acquiring an additional 294 shares in the last quarter. Optiver Holding B.V. bought a new position in shares of Medtronic during the 4th quarter worth approximately $31,000. Finally, Chapman Financial Group LLC bought a new position in shares of Medtronic during the 4th quarter worth approximately $33,000. 82.06% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on MDT shares. Robert W. Baird raised their price target on shares of Medtronic from $90.00 to $91.00 and gave the stock a "neutral" rating in a research note on Wednesday, February 19th. Truist Financial decreased their price target on shares of Medtronic from $93.00 to $90.00 and set a "hold" rating for the company in a research note on Friday, April 11th. UBS Group raised their price target on shares of Medtronic from $85.00 to $95.00 and gave the stock a "neutral" rating in a research note on Wednesday, February 19th. Royal Bank of Canada reissued an "outperform" rating and issued a $105.00 price objective on shares of Medtronic in a report on Wednesday, February 19th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Medtronic in a report on Monday. One analyst has rated the stock with a sell rating, eight have issued a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, Medtronic has a consensus rating of "Hold" and a consensus target price of $96.14.

Medtronic Stock Performance

Shares of MDT traded down $0.78 during midday trading on Tuesday, reaching $86.19. 9,247,065 shares of the stock were exchanged, compared to its average volume of 6,760,179. Medtronic plc has a twelve month low of $75.96 and a twelve month high of $96.25. The company has a quick ratio of 1.39, a current ratio of 1.90 and a debt-to-equity ratio of 0.48. The stock's 50 day simple moving average is $85.83 and its 200 day simple moving average is $86.57. The company has a market cap of $110.54 billion, a P/E ratio of 26.20, a PEG ratio of 2.22 and a beta of 0.81.

Medtronic (NYSE:MDT - Get Free Report) last issued its quarterly earnings data on Tuesday, February 18th. The medical technology company reported $1.39 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.03. Medtronic had a net margin of 12.83% and a return on equity of 14.07%. The business had revenue of $8.29 billion during the quarter, compared to analysts' expectations of $8.33 billion. On average, sell-side analysts expect that Medtronic plc will post 5.46 earnings per share for the current year.

Medtronic Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were given a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a yield of 3.25%. The ex-dividend date of this dividend was Friday, March 28th. Medtronic's dividend payout ratio is presently 85.11%.

Medtronic Company Profile

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.